Trial Profile
PE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2022
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Atherosclerosis
- Focus Registrational; Therapeutic Use
- Sponsors Boston Scientific Corporation
- 15 Dec 2015 New trial record